AI-generated summary
The authors report a randomized, double-blind, placebo-controlled trial of 904 nm photobiomodulation at three energy densities in 80 volunteers with non-infected diabetic foot ulcers, all receiving conventional dressing care. They found ulcer size reduction across energy densities, with the 10 J/cm2 group showing the highest proportion of completely healed ulcers and the only significant difference from control at 10 weeks. The abstract does not describe the study as a large trial beyond the 80 participants.
- Participants
- 80
- Who or what was studied
- Volunteers with non-infected diabetic foot ulcers (48.75% female; mean age 58.5 ± 11.1 years)
- Wavelengths
- 904 nm
- Limits stated in the abstract
- The abstract reports only a single trial of 80 participants with no discussion of limits beyond the randomized design, and the 10 J/cm2 findings rest on subgroup-style comparisons with the primary outcome reported as ulcer size reduction rate.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on link.springer.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 904 nm
- Energy density (fluence)
- 4 J/cm2, 8 J/cm2, 10 J/cm2
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation, Randomized controlled trial, Dose, Fluence, Control group, Placebo-controlled, Trial registration. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.